Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Communications technology for students and employees to manage their healthcare relationships

Allviant Corporation today announced the launch of its CarePass™ pilot program with Arizona State University to add another tool to the university’s health and wellness communications and services while empowering its employees and students with tools to manage their healthcare relationships.

12 Oct 2009

ImmuneRegen BioSciences to test efficacy of Homspera against H5N1 Avian Influenza

ImmuneRegen BioSciences, Inc.®, a wholly owned subsidiary of IR Biosciences Holdings, Inc. (OTCBB: IRBS), today announced that its lead anti-influenza drug, Homspera, will be tested for efficacy against highly lethal H5N1 Avian Influenza in the laboratories of a widely respected University scientist. Additionally, testing at an independent facility will further define the adjuvant efficacy of Homspera when coupled with a novel vaccine for H5N1 in studies sponsored by an ImmuneRegen industry partner.

12 Oct 2009

Public forum and scientific workshop on women's health issues

The Northwestern University Feinberg School of Medicine and Northwestern Memorial Hospital will host a public forum and scientific workshop Oct. 14 to 16 to discuss emerging issues of importance for the National Institutes of Health (NIH) for women's health research in the coming decade.

12 Oct 2009

NIH to launch 2009 H1N1 influenza vaccine trials in HIV-infected pregnant women, children and youth

The first clinical trials to test whether the 2009 H1N1 influenza vaccine can safely elicit a protective immune response in pregnant women launched yesterday, and a trial to conduct the same test in HIV-infected children and youth will begin next week.

12 Oct 2009

Presentations on efficacy of interferon to combat influenza

Amarillo Biosciences, Inc. (ABI) today announced that Professor Dr. Otto Haller from the Department of Virology, Freiburg University, Germany and Professor Dr. Oliver Planz from the Friedrich Loeffler Institute, Tubingen, Germany gave two separate presentations on the efficacy of interferon to combat influenza.

12 Oct 2009

Wal-Mart Stores to offer Tamiflu oral suspension in liquid form for children and elderly

Wal-Mart Stores, Inc. announced today that more than 4,000 Walmart and Sam's Club pharmacies nationwide will address the national shortage of Tamiflu® oral suspension by converting the capsule to liquid form.

12 Oct 2009

NIH launches trial for the determination of 2009 H1N1 influenza vaccine for asthma patients

The National Institutes of Health is preparing to launch the first government-sponsored clinical trial to determine what dose of the 2009 H1N1 influenza vaccine is needed to induce a protective immune response in people with asthma, especially those with severe disease.

12 Oct 2009

AP examines H1N1 surveillance by U.S., WHO

The Associated Press examines how the decision by U.S. health officials to stop counting new cases of H1N1 (swine flu) in July has complicated the government's ability to assess groups particularly hard hit by the virus.

9 Oct 2009

Recent releases in Global Health

A Lancet comment examines an Affordable Medicines Facility for malaria (AMFm) program to help countries procure subsidized artemisinin-based combination treatments (ACTs).

9 Oct 2009

Agriculture investment in developing countries must increase by 50% to feed 9.1B people by 2050, FAO report says

Developing countries need agriculture investments of $83 billion per year to meet the food needs of a projected

9 Oct 2009

A three-month study reveals the impact of swine flu on the health of the general public in Australia and New Zealand

A comprehensive study has revealed, for the first time, the impact of swine flu on the health of the general public in Australia and New Zealand.

9 Oct 2009

State governments start swine flu vaccine campaign

Questions, answers and reactions emerge as various states and counties distribute H1N1 flu vaccines.

9 Oct 2009

CREON Delayed-Release Capsules improves fat absorption in patients with Cystic Fibrosis

Solvay Pharmaceuticals, Inc. announced that Phase III data published in the Journal of Cystic Fibrosis showed that CREON® (pancrelipase) Delayed-Release Capsules, the most prescribed pancreatic enzyme replacement therapy (PERT) in the United States, significantly improves a key measure of fat absorption in patients with CF who suffer from exocrine pancreatic insufficiency (EPI).

9 Oct 2009

Cantel Medical announces fiscal 2009 fourth-quarter and full-year financial results

CANTEL MEDICAL CORP. reported a 65% increase in net income to $4,279,000, or $0.26 per diluted share, on a 4% increase in sales to a record $66,793,000 for the fourth quarter ended July 31, 2009. This compares with net income of $2,596,000, or $0.16 per diluted share, on sales of $64,281,000 for the fourth quarter ended July 31, 2008.

9 Oct 2009

MedaSorb Technologies raises $1.3 million to help finance ongoing European Sepsis Trial

MedaSorb Technologies Corporation and its wholly-owned subsidiary CytoSorbents, Inc., announced that it has raised $1.3 million in the exercise of the warrant attached to the Series B financing completed in August 2008. Dr. Phillip Chan, Chief Executive Officer, stated, "We are pleased to have the continued support of our existing investors.

9 Oct 2009

Aspen Institute and TIME magazine to present panel discussions on health care reform

With health care reform headed to the floor of the House and Senate, the Aspen Institute and TIME magazine will present a day of panel discussions designed to shed light on what the looming changes will mean for the American people.

9 Oct 2009

Verichip Corporation's H1N1 virus triage detection system to feature in Fox News

VeriChip Corporation has announced that the Company is scheduled to be featured on the Glenn Beck show on Fox News today, October 8, 2009 during the 5 p.m. hour. Glenn Beck intends to dedicate today's show to the H1N1 virus and will feature VeriChip, its Health Link personal health record and its H1N1 virus triage detection system currently being developed with partner RECEPTORS LLC, as part of the show.

9 Oct 2009

LeVOCC air purification system destroys the PR8 strain of the H1N1 virus

LeVOCC, Inc. today announced that independent laboratory testing has conclusively demonstrated that the LeVOCCTM air purification system successfully destroys a strain of the H1N1 virus. Testing was conducted using the Puerto Rico 8 (PR8) strain of the H1N1 virus. This strain is an influenza A H1N1 seasonal strain and is a valid representative of all H1N1 strains.

9 Oct 2009

Medicago receives contract from U.S. Army Research, Development and Engineering Command laboratory

Medicago Inc. (TSX-V: MDG), a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has been awarded a proof of concept contract by the U.S. Army Research, Development and Engineering Command laboratory specifically the Edgewood Chemical Biological Center ("ECBC") Research & Technology Directorate.

9 Oct 2009

Persistent, growing disparities underscore the need for national reform

The cost and quality of health care, as well as access to care and health outcomes, continue to vary widely among states, according to the Commonwealth Fund Commission on a High Performance Health System's second state scorecard report released today.

9 Oct 2009

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Communications technology for students and employees to manage their healthcare relationships

ImmuneRegen BioSciences to test efficacy of Homspera against H5N1 Avian Influenza

Public forum and scientific workshop on women's health issues

NIH to launch 2009 H1N1 influenza vaccine trials in HIV-infected pregnant women, children and youth

Presentations on efficacy of interferon to combat influenza

Wal-Mart Stores to offer Tamiflu oral suspension in liquid form for children and elderly

NIH launches trial for the determination of 2009 H1N1 influenza vaccine for asthma patients

AP examines H1N1 surveillance by U.S., WHO

Recent releases in Global Health

Agriculture investment in developing countries must increase by 50% to feed 9.1B people by 2050, FAO report says

A three-month study reveals the impact of swine flu on the health of the general public in Australia and New Zealand

State governments start swine flu vaccine campaign

CREON Delayed-Release Capsules improves fat absorption in patients with Cystic Fibrosis

Cantel Medical announces fiscal 2009 fourth-quarter and full-year financial results

MedaSorb Technologies raises $1.3 million to help finance ongoing European Sepsis Trial

Aspen Institute and TIME magazine to present panel discussions on health care reform

Verichip Corporation's H1N1 virus triage detection system to feature in Fox News

LeVOCC air purification system destroys the PR8 strain of the H1N1 virus

Medicago receives contract from U.S. Army Research, Development and Engineering Command laboratory

Persistent, growing disparities underscore the need for national reform

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in